Determinants and predictors of outcome in super refractory status epilepticus-A developing country perspective

Epilepsy Research

Volumn 108, Issue 9, 2014, Pages 1609-1617

  Jayalakshmi, Sita ^a   Ruikar, Devashish ^a   Vooturi, Sudhindra ^a   Mohandas, Surath ^a   Alladi, Suvarna ^b   Kaul, Subhash ^b   Sahu, Sambit ^a  

^a KRISHNA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acidosis; Encephalitis; Mortality; Status epilepticus; Super refractory status epilepticus

Indexed keywords

ACIDOSIS; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPING COUNTRY; ENCEPHALITIS; EPILEPTIC STATE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GLASGOW COMA SCALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN STUDY; SUPER REFRACTORY STATUS EPILEPTICUS; SURVIVAL TIME; ADOLESCENT; COMPLICATION; ELECTROENCEPHALOGRAPHY; GLASGOW OUTCOME SCALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE; STATISTICAL MODEL; STATUS EPILEPTICUS; TREATMENT OUTCOME; YOUNG ADULT;

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ANTICONVULSANTS; COHORT STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; STATUS EPILEPTICUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908004637     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.08.010     Document Type: Article

References (49)

1. Chen L., Zhou B., Li J.M., Zhu Y., Wang J.H., Sander J.W., Stefan H., Zhou D. Clinical features of convulsive status epilepticus: a study of 220 cases in western China. Eur. J. Neurol. 2009, 16:444-449.
2. Chin R.F., Neville B.G., Peckham C., Bedford H., Wade A., Scott R.C. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006, 368:222-229.
3. Claassen J., Hirsch L.J., Emerson R.G., Mayer S.A. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43:146-153.
4. Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000, 55:693-697.
5. DeLorenzo R.J., Pellock J.M., Towne A.R., Boggs J.G. Epidemiology of status epilepticus. J. Clin. Neurophysiol. 1995, 12:316-325.
6. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., Garnett L., Fortner C.A., Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
7. Falconer M.A., Serafetinides E.A., Corsellis J.A. Etiology and pathogenesis of temporal lobe epilepsy. Arch. Neurol. 1964, 10:233-248.
8. Fountain N.B. Status epilepticus: risk factors and complications. Epilepsia 2000, 41(Suppl 2):S23L 30.
9. Garzon E., Fernandes R.M., Sakamoto A.C. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure 2003, 12:337-345.
10. Granerod J., Ambrose H.E., Davies N.W., Clewley J.P., Walsh A.L., Morgan D., Cunningham R., Zuckerman M., Mutton K.J., Solomon T., Ward K.N., Lunn M.P., Irani S.R., Vincent A., Brown D.W., Crowcroft N.S. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect. Dis. 2010, 10:835-844.
11. Gunnerson K.J., Saul M., He S., Kellum J.A. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit. Care 2006, 10:R22.
12. Hauser W.A. Status epilepticus: epidemiologic considerations. Neurology 1990, 40:9-13.
13. Hocker S.E., Britton J.W., Mandrekar J.N., Wijdicks E.F., Rabinstein A.A. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013, 70:72-77.
14. Holtkamp M. The anaesthetic and intensive care of status epilepticus. Curr. Opin. Neurol. 2007, 20:188-193.
15. Holtkamp M., Othman J., Buchheim K., Masuhr F., Schielke E., Meierkord H. A malignant variant of status epilepticus. Arch. Neurol. 2005, 62:1428-1431.
16. Holtkamp M., Othman J., Buchheim K., Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J. Neurol. Neurosurg. Psychiatry 2005, 76:534-539.
17. Jallon P., Coeytaux A., Galobardes B., Morabia A. Incidence and case-fatality rate of status epilepticus in the Canton of Geneva. Lancet 1999, 353:1496.
18. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
19. Joshi R., Kalantri S.P., Reingold A., Colford J.M. Changing landscape of acute encephalitis syndrome in India: a systematic review. Natl. Med. J. India 2012, 25:212-220.
20. Kellum J.A., Song M., Li J. Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R686-R692.
21. Kennedy P.G., Chaudhuri A. Herpes simplex encephalitis. J. Neurol. Neurosurg. Psychiatry 2002, 73:237-238.
22. Khetsuriani N., Holman R.C., Anderson L.J. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin. Infect. Dis. 2002, 35:175-182.
23. Kilbride R.D., Reynolds A.S., Szaflarski J.P., Hirsch L.J. Clinical outcomes following prolonged refractory status epilepticus (PRSE). Neurocrit. Care 2013, 18:374-385.
24. Knake S., Rosenow F., Vescovi M., Oertel W.H., Mueller H.H., Wirbatz A., Katsarou N., Hamer H.M. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001, 42:714-718.
25. Koubeissi M., Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 2007, 69:886-893.
26. Kowalski R.G., Ziai W.C., Rees R.N., Werner J.K., Kim G., Goodwin H., Geocadin R.G. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit. Care Med. 2012, 40:2677-2684.
27. Krishnamurthy K.B., Drislane F.W. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996, 37:863-867.
28. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., Cohen J., Opal S.M., Vincent J.L., Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003, 31:1250-1256.
29. Logroscino G., Hesdorffer D.C., Cascino G., Annegers J.F., Hauser W.A. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997, 38:1344-1349.
30. Lowenstein D.H., Alldredge B.K. Status epilepticus at an urban public hospital in the 1980. Neurology 1993, 43:483-488.
31. Lowenstein D.H., Alldredge B.K. Status epilepticus. N. Engl. J. Med. 1998, 338:970-976.
32. Lowenstein D.H., Bleck T., Macdonald R.L. It's time to revise the definition of status epilepticus. Epilepsia 1999, 40:120-122.
33. Mayer S.A., Claassen J., Lokin J., Mendelsohn F., Dennis L.J., Fitzsimmons B.F. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch. Neurol. 2002, 59:205-210.
34. Murthy J.M., Jayalaxmi S.S., Kanikannan M.A. Convulsive status epilepticus: clinical profile in a developing country. Epilepsia 2007, 48:2217-2223.
35. Novy J., Logroscino G., Rossetti A.O. Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51:251-256.
36. Oxbury J.M., Whitty C.W. Causes and consequences of status epilepticus in adults. A study of 86 cases. Brain 1971, 94:733-744.
37. Potharaju N.R. Incidence rate of acute encephalitis syndrome without specific treatment in India and Nepal. Indian J. Community Med. 2012, 37:240-251.
38. Rossetti A.O., Logroscino G., Bromfield E.B. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch. Neurol. 2005, 62:1698-1702.
39. Sahin M., Menache C.C., Holmes G.L., Riviello J.J. Outcome of severe refractory status epilepticus in children. Epilepsia 2001, 42:1461-1467.
40. Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia 2011, 52(Suppl 8):53-56.
41. Shorvon S., Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012, 135:2314-2328.
42. Standley K., Abdulmassih R., Benbadis S. Good outcome is possible after months of refractory convulsive status epilepticus: lesson learned. Epilepsia 2012, 53:e17-e20.
43. Sutter R., Marsch S., Fuhr P., Ruegg S. Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study. Epilepsia 2013, 54:502-511.
44. Sutter R., Tschudin-Sutter S., Grize L., Fuhr P., Bonten M.J., Widmer A.F., Marsch S., Ruegg S. Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. Epilepsia 2012, 53:1489-1497.
45. Towne A.R., Pellock J.M., Ko D., DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
46. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., Handforth A., Faught E., Calabrese V.P., Uthman B.M., Ramsay R.E., Mamdani M.B. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl. J. Med. 1998, 339:792-798.
47. Vadlamudi L., Scheffer I.E., Berkovic S.F. Genetics of temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry 2003, 74:1359-1361.
48. Waterhouse E.J., Garnett L.K., Towne A.R., Morton L.D., Barnes T., Ko D., DeLorenzo R.J. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 1999, 40:752-758.
49. Wu Y.W., Shek D.W., Garcia P.A., Zhao S., Johnston S.C. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002, 58:1070-1076.